LOS ANGELES--(BUSINESS WIRE)--BioTools Innovator, the first accelerator dedicated to supporting life science tools and diagnostics startups, announced today that 20 companies have been selected to participate in its annual BioTools Innovator Accelerator, a four-month program providing in-depth, customized mentorship from senior industry leaders, funding opportunities, and engagement with peers and advisors.
The 2024 cohort was chosen by the BioTools Innovator selection committee including the senior leadership teams of the program’s corporate partners, Research Corporation Technologies (RCT), BroadOak Capital Partners, and Nissan Chemical America Corporation, and with input from more than 130 industry judges from leading life science firms.
The top 20 companies were selected to participate from a pool of more than 300 applicants from 33 countries and 35 U.S. states. The BioTools Innovator 2024 Cohort will attend the program’s kick off, joining the MedTech Innovator U.S. and Asia Pacific cohorts at the invitation-only Innovator Summit 2024 on June 12-13. This event connects the leadership teams from the latest cohorts with MTI’s partners, alumni, and other industry leaders.
“Now in its fourth year, BioTools Innovator’s mission is to nurture the life science entrepreneurs whose technologies enable more efficient drug discovery and development processes, and faster and more accurate diagnostics,” said Kathryn Zavala, managing director of BioTools Innovator. “With the expertise and guidance of distinguished thought leaders in the biotools and diagnostics industries, our innovators are better positioned to meaningfully contribute to the advancement of human health."
The 20 companies awarded a spot in the BioTools Innovator 2024 Accelerator are:
Anvil Diagnostics - Cambridge, Mass.
Autolomous - London
Axolotl Biosciences - Victoria, BC
CellRev - Newcastle Upon Tyne, UK
Cerillo - Charlottesville, Va.
CytoRecovery - Blacksburg, Va.
EmGenisys - Houston
EpiPaws - Fort Lauderdale, Fla.
FemtoFluidics - Excelsior, Minn.
Life Magnetics - Ann Arbor, Mich.
Narwhal Bio - San Diego
Nyctea Technologies - Gothenburg, Sweden
Pluto Bio - Denver
Polybiomics - Berkeley, Calif. and Seattle
QurCan Therapeutics - Toronto, ON and Cambridge, Mass.
React4Life - Genoa, Italy
Redbud Labs - Research Triangle Park, N.C.
Ryght - Laguna Beach, Calif.
Sarcura - Klosterneuburg, Austria
Syenex - Chicago
BioTools Innovator thanks our expert ecosystem including representatives from Agilent, Becton Dickinson, Biomedical Advanced Research and Development Authority (BARDA), Catalent Pharma Solutions, Danaher, Draper, Eppendorf, Foresite Labs, Genentech, General Inception, Genoa Ventures, Illumina Ventures, Johnson & Johnson Innovation, Northpond Ventures, PacBio, Qiagen, Thermo Fisher Scientific, Teknova, and VC23, among others for participating in this year’s program as mentors, judges and advisors.
Funding for BioTools Innovator is provided by the Frederick Gardner Cottrell Foundation of RCT. Additional support is provided by BroadOak Capital Partners and Nissan Chemical America Corporation.
About BioTools Innovator
Based in Los Angeles, BioTools Innovator was established to advance cutting-edge research and improve human health by accelerating the growth of a broad spectrum of life science tools and diagnostics. BioTools Innovator matches industry leaders with innovative early stage and emerging growth biotechnology-focused companies for mentorship and support.
BioTools Innovator is powered by MedTech Innovator, the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. To date, MedTech Innovator has supported 612 alumni that have gone on to raise over $8 billion in follow-on funding, brought 310 products to market, and achieved 45 exits.
For more information about BioTools Innovator, visit the website, and follow the organization on LinkedIn.
